Published in Gene Therapy Weekly, March 29th, 2012
The Cell-in-a-Box® technology involves the encapsulation of cytochrome P450 expressing cells which are placed beside the target tumor. When the patient is injected with the nontoxic drug ifosfamide, the encapsulated cells transform this prodrug into its active, chemotherapeutic drug. The greatest benefit of this treatment protocol is that the treatment is localized...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.